Clinical Trials Logo

Filter by:
NCT ID: NCT00279045 Completed - Clinical trials for Diabetes Mellitus, Type 2

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Start date: January 3, 2000
Phase: Phase 3
Study type: Interventional

The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.

NCT ID: NCT00278980 Completed - Clinical trials for Diabetes Mellitus, Type 1

Effect of C-Peptide on Diabetic Peripheral Neuropathy

Start date: October 2003
Phase: Phase 2
Study type: Interventional

The aim of the study is to investigate the effect of C-peptide administration on nerve function in patients with type 1 diabetes and peripheral sensory neuropathy.

NCT ID: NCT00276757 Completed - Clinical trials for Childhood Langerhans Cell Histiocytosis

Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis

Start date: April 2001
Phase: N/A
Study type: Interventional

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of Langerhans cell histiocytosis, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may be an effective treatment for Langerhans cell histiocytosis. PURPOSE: This randomized clinical trial is studying combination chemotherapy to see how well it works in treating young patients with Langerhans cell histiocytosis.

NCT ID: NCT00275457 Completed - Clinical trials for Restless Legs Syndrome

Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients

Start date: October 2002
Phase: Phase 3
Study type: Interventional

To evaluate safety and efficacy of pramipexole in the treatment of patients suffering from moderate to severe RLS over 6 weeks under double blinded conditions followed by a 46 week open label or double blind extension.

NCT ID: NCT00275210 Completed - Colonic Neoplasms Clinical Trials

MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Start date: October 1998
Phase: Phase 3
Study type: Interventional

To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III colon cancer. Primary objective: Disease Free Survival (DFS) Secondary objective: Overall Survival (OS), safety (including long term toxicity)

NCT ID: NCT00274560 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

Start date: May 1, 2002
Phase: Phase 3
Study type: Interventional

The objective of the study was to evaluate the degree of improvement in lung function in patients with chronic obstructive pulmonary disease (COPD) after treatment with tiotropium inhalation capsules compared to salmeterol inhalation aerosol .

NCT ID: NCT00274326 Completed - Clinical trials for Congestive Heart Failure

DILIPO (DILutIonal HyPOnatremia)

Start date: May 2005
Phase: Phase 3
Study type: Interventional

Primary: - To assess the efficacy of SR121463B in correcting hyponatremia in patients with dilutional hyponatremia other than SIADH or cirrhosis Secondary: - To assess the long-term efficacy of SR121463B in maintaining normonatremia in these patients - To assess the safety and tolerability of SR121463B

NCT ID: NCT00274118 Completed - Hypertension Clinical Trials

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Start date: July 1997
Phase: Phase 3
Study type: Interventional

To compare the renal consequences of two different approaches to blocking the renin angiotensin system in subjects with hypertension and concurrent Type II diabetes mellitus and diabetic nephropathy.

NCT ID: NCT00272948 Completed - Clinical trials for Hepatic Veno-Occlusive Disease

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide

VOD-DF
Start date: December 2005
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this trial is to evaluate whether the prophylactic use of Defibrotide (DF) in pediatric patients (age less than 18 years) undergoing stem cell transplantation and who are at high risk of developing hepatic Veno-occlusive Disease (VOD) will have an impact on the incidence and severity of the disease. Patients will be randomly assigned to one of two treatment arms: Those allocated to the Prophylactic Arm will receive the study drug (Defibrotide) from the day of conditioning onwards. Patients allocated to the Control Arm will receive the study drug (Defibrotide) from the day that VOD is diagnosed.

NCT ID: NCT00272701 Completed - Clinical trials for Gastroesophageal Reflux Disease

Esomeprazole in PPI Failures - IMPROVE

Start date: December 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to assess how PPI treated GERD patients with insufficient symptom control will benefit from a change in management by providing a more efficient acid secretion inhibition during 4 weeks, by evaluation of esomeprazole 40 mg compared to pre-study PPI treatment.